Conway Capital Management, Inc. Gt Biopharma, Inc. Transaction History

Conway Capital Management, Inc.

  • $206 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Dec 02, 2024
SELL
$6.68 - $15.26 $136,940 - $312,830
-20,500 Closed
0 $0
Q2 2021

Dec 02, 2024
BUY
$7.19 - $18.96 $10,785 - $28,440
1,500 Added 7.89%
20,500 $318 Million
Q1 2021

Dec 02, 2024
BUY
$4.4 - $8.84 $83,600 - $167,960
19,000 New
19,000 $130 Million

Others Institutions Holding GTBP

# of Institutions
4
Shares Held
564
Call Options Held
0
Put Options Held
0
View Full List

About GT Biopharma, Inc.

GTBP Quotes by TradingView
  • Ticker GTBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 32,557,700
  • Market Cap $81.7M
  • Description
  • GT Biopharma, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of immuno-oncology products based on its proprietary Tri-specific Killer Engager (TriKE) fusion protein immune cell engager technology platform. It develops GTB-3550, a single-chain tri-specific recombinant fusion protein conjugate th...
More about GTBP
Track This Portfolio

Track Conway Capital Management, Inc. Portfolio

Follow Conway Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Conway Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conway Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email